ArticleMolecular therapy : the journal of the American Society of Gene Therapy2013

Transient removal of CD46 is safe and increases B-cell depletion by rituximab in CD46 transgenic mice and macaques.

Ines Beyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.